Current Treatment Options Available for COVID-19 : A Review

  • Mehta M
  • et al.
N/ACitations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

The World Health Organization (WHO) introduced the term 2019 novel corona virus to refer to a corona virus that affected the lower respiratory tract of patients with pneumonia in Wuhan, China. The official name of the 2019 novel corona virus is corona virus disease (COVID-19), announced by WHO. The total reported cases of COVID-19 as of 15th June, 2020 are 79,95,877 and 4,35,598 reported deaths. Non-availability of vaccines and medicines for its treatment is really threatening to the world right now. All chloroquine and Hydroxychloroquine, antibacterial therapy like azithromycin and doxycycline, antiviral therapy like lopinavir/ritonavir and remdesivir, convalescent plasma therapy, zinc, vaccines and Tocilizumab are part of possible management options and none is officially approved for the treatment. Current review of various articles by searching on PubMed is initiated with intention of creating meaningful information regarding all possible management that is available or will be available in near future of COVID-19.

Cite

CITATION STYLE

APA

Mehta, M., & Patharkar, J. (2020). Current Treatment Options Available for COVID-19 : A Review. Asian Journal of Pharmaceutical Research and Health Care, 12(3), 141–147. https://doi.org/10.18311/ajprhc/2020/25540

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free